29 research outputs found
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
Full text linkExecutive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)
No full textExecutive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015)
No full textEvaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients
No full textExecutive summary of the consensus statement on assistance to women with HIV infection in the health care sector
No full textCost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults
No full textKidney transplantation in human immunodeficiency virus-infected patients: a report of two cases and a review of the literatures
No full text
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching from Ritonavir-Boosted Protease Inhibitors to Raltegravir
No full textInfluence of the number of daily pills and doses on adherence to antiretroviral treatment: a 7-year study
No full text
